Rosiglitazone Evaluated for Cadiac Outcomes and Regulation of Glycemia in Diabetes (RECORD): A long-term cardiovascular Outcome study - Home P and Gubb J for the RECORD study steering committee and,i.nvestigators. (Diabetes, 2002)